Real-world safety and efficacy of teclistamab in relapsed/refractory multiple myeloma: results from a multicenter, retrospective study and descriptive meta-analysis.
Varma G, Fogel L, Gordon B, Saldarriaga MM, Ahn J, Aleman A, Caro J, Rosenberg MC, Monge J, Parmar H, Kaminetzky D, Moskovits T, Siegel DS, Morgan GJ, Niesvizky R, Davies FE, Biran N.
Varma G, et al. Among authors: siegel ds.
Leuk Lymphoma. 2025 Jan 5:1-10. doi: 10.1080/10428194.2024.2446617. Online ahead of print.
Leuk Lymphoma. 2025.
PMID: 39756041